Lundbeck posted quarterly revenue of 6.09 billion Danish kroner ($960 million), an increase of 10% on a year ago, and adjusted EBITDA of 1.61 billion kroner, up 40%. Adjusted earnings per share (EPS) ...
Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...
Emcure Pharma's Q3 FY26 net profit rose 48% on strong domestic and international growth, as the company eyes entry into India ...
JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...
Eli Lilly and Company (NYSE:LLY) reported fourth-quarter financial results on Wednesday. The transcript from the earnings call has been provided below.
Dicamba, a drift-prone herbicide, is slated to be reapproved by EPA in the coming days, despite a long history of adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results